Últimas noticias sobre Federated Hermes (NYSE:FHI) Bolsa

Federated Hermes

Federated Hermes provides asset-management services for institutional and individual investors. The firm had $840 billion in managed assets at the end of March 2025, composed of equity (10%), multi-asset (less than 1%), fixed-income (12%), alternative (2%), and money market (76%) funds. The firm's cash-management operations are expected to generate around 54% of Federated's revenue this year, compared with 29%, 12%, and 6%, respectively, for the equity, fixed-income, and alternatives/multi-asset operations. The company's products are distributed via trust banks, wealth managers, and retail broker/dealers (67% of AUM), institutional investors (26%), and international clients (7%).

Federated Hermes Inc

FREEHILL MINING LTD by Freehill Mining Ltd

Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) has outperformed the market over the past 10 years by 4.5% on an annualized basis producing an average annual return of 15.79%. Currently, Hilton Worldwide Holdings has a market capitalization of $59.98 billion. 
Buying $1000 In HLT: If an investor had bought $1000 of HLT stock 10 years ago, it would be worth $4,367.39 today based on a price of $252.34 for HLT at the time of writing.
<h3>Hilton Worldwide Holdings's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750711521_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

$1000 Invested In Hilton Worldwide Holdings 10 Years Ago Would Be Worth This Much Today

WIIM

KBH stock has given up its prior loss. KB Home shares were trading lower following Q2 financial results.

<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1501697/000162828025032627/xfor-20250623.htm">https://www.sec.gov/ix?doc=/Archives/edgar/data/1501697/000162828025032627/xfor-20250623.htm</a>

General

XFOR

X4 Pharmaceuticals Enters Purchase Agreement With Lincoln Park; Can Sell Up To $40M In Stock

Biotech

LQDA

Liquidia Secures $50M From Healthcare Royalty After First YUTREPIA Commercial Sale

NKTR

Nektar Therapeutics shares are trading higher after the company announced it will release top-line data from the 16-week induction period in the ongoing global Phase 2b REZOLVE-AD clinical trial of investigational rezpegaldesleukin on June 24, 2025.

Happy City Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCHL#NASDAQ">HCHL</a>) (the "Company"), an established all-you-can-eat hotpot restaurant operator in Hong Kong , today announced the pricing of its initial public offering (the "Offering") of 1,100,000 Class A ordinary shares (the "Class A Ordinary Shares"), at a price of $5.00 per Class A Ordinary Share (the "Offering Price").
The Class A Ordinary Shares are expected to begin trading on the Nasdaq Capital Market on June 24, 2025 under the symbol "HCHL." The Offering is expected to close on June 25, 2025, subject to the satisfaction of customary closing conditions.
The Company expects to receive aggregate gross proceeds of US$5.5 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 165,000 Class A Ordinary Shares of the Company, at the Offering Price, representing 15% of the Class A Ordinary Shares sold in the Offering (the "Over-allotment Option"). Assuming that the Over-allotment Option is exercised, the Company is expected to receive gross proceeds amounting to $6.325 million, before deducting underwriting discounts and commissions and estimated offering expenses.
The Company intends to use the net proceeds for its business expansion in Hong Kong and Southeast Asia region and working capital and general corporate purposes.

IPOs

HCHL

Happy City Holdings Prices IPO Of 1.10M Class A Ordinary Shares At $5/Shr

CORT

Corcept Therapeutics Reveals That Catalyst Trial Meets Primary Endpoint With Improvement In HbA1c; Catalyst Trial Meets Secondary Endpoints With Reduced Body Weight And Waist Circumference

Diversified Energy Company PLC ((LSE: DEC, NYSE:<a href="https://www.benzinga.com/stock/DEC#NYSE">DEC</a>) ("Diversified," or "DEC"), a leading publicly traded natural gas and liquids production company, and global investment firm Carlyle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>) have today announced a strategic partnership to invest in up to $2 billion in existing proved developed producing (PDP) natural gas and oil assets across the United States.
This exclusive partnership will combine Carlyle's deep credit and structuring expertise, led by Carlyle's asset-backed finance (ABF) team, with Diversified's market-leading operating capabilities and differentiated business model of acquiring and optimizing portfolios of existing long-life oil and gas assets to generate reliable production and consistent cash flow.
The partnership enhances Diversified's access to capital in an attractive acquisition market. Under the terms of the agreement, Diversified will serve as the operator and servicer of the newly acquired assets. As investments occur, Carlyle intends to pursue opportunities to securitize these assets, seeking to unlock long-term, resilient financing for this critical segment of the nation's energy infrastructure.
"We are excited to partner with Carlyle, a leader in the asset-backed finance space. This arrangement significantly enhances our ability to pursue and scale strategic acquisitions in what we believe is a highly compelling environment for PDP asset consolidation," said Rusty Hutson, Jr., CEO of Diversified Energy. "We continue to see a robust pipeline of opportunities and the growing need for operational scale and efficiency. With Carlyle's support, we are well-positioned to capitalize on these trends while aiming to generate sustainable cash flow and value for our shareholders."
"Diversified is a leading operator of long-life energy assets and a pioneer in bringing PDP securitizations to institutional markets," said Akhil Bansal, Head of Asset-Backed Finance at Carlyle. "We are excited to bring institutional capital to high-quality, cash-yielding energy assets that are core to US domestic energy production and energy security. This partnership underscores Carlyle's ability to originate differentiated investment opportunities through proprietary sourcing channels and seek access to stable, yield-oriented energy exposure."
Carlyle Asset-Backed Finance ("Carlyle ABF") is a group within Carlyle's Global Credit platform focused on private fixed income and asset-backed investments. The highly experienced team leverages the knowledge, sourcing, structuring, and breadth of the entire Carlyle investment platform to help deliver tailored asset-focused financing solutions to businesses, specialty finance companies, banks, asset managers, and other originators and owners of diversified pools of assets. Carlyle ABF has deployed approximately $8 billion since 2021 and has approximately $9 billion in assets under management as of March 31, 2025.

Contracts

Diversified Energy and Carlyle Enters Strategic Partnership And Will Invest Up To $2B Of Proved Developed Producing (PDP) Natural Gas And Oil Assets Across The United States

In a signal of changing investor sentiment and strategic refocusing, top asset managers such as BlackRock and Goldman Sachs, are shutting down <a href="https://www.benzinga.com/etfs">several ETFs</a>, many of which have an environmental, social, and governance (ESG) theme.
Also Read: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/06/46060843/vanguard-etfs-lead-2025-with-150-billion-inflows-challenging-wall-streets-old-guard">Vanguard ETFs Lead 2025 With $150 Billion Inflows, Challenging Wall Street&#8217;s Old Guard</a>
BlackRock, the largest ETF issuer globally with $3.4 trillion in U.S. assets, <a href="https://www.businesswire.com/news/home/20250613921212/en/BlackRock-Announces-Product-Updates">closed </a>eight ETFs and six mutual funds, of which three are ESG-themed. The combined assets of the closed ETFs total approximately $109 million. Although BlackRock did not mention the lack of demand directly, management stated in the press release that they &#8220;constantly assess how our funds are meeting investors' investment objectives and the evolving needs of our clients,&#8221; which was indicative of a demand slowdown.
Goldman Sachs, for its part, <a href="https://www.businesswire.com/news/home/20250618717138/en/Goldman-Sachs-Asset-Management-Announces-Liquidation-of-Two-Exchange-Traded-Funds" target="_blank" rel="noopener">shut </a>down two thematic funds on June 18—the Future Consumer Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBUY#NYSE">GBUY</a>) and the Future Planet Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSFP#NYSE">GSFP</a>)—with a total of $29.7 million in assets.
Earlier this month, VanEck <a href="https://www.benzinga.com/etfs/new-etfs/25/06/45800049/vaneck-shutters-esg-etfs-rnew-smi-amid-low-demand-for-green-investment-funds" target="_blank" rel="noopener">also announced shutting down</a> its Green Infrastructure ETF and HIP Sustainable Muni ETF, attributing the decision to poor performance and a lack of investor interest. The funds had their last trading day on June 18, with liquidating payouts to be made around June 25.
These closures are indicative of a larger industry trend whereby asset managers are grouping underperforming or low-demand funds. 
While ESG investing is a continued theme for most portfolios, the most recent round of closures indicates that not all sustainability funds have long-term staying power in an increasingly dynamic market.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/06/46056666/how-a-strait-of-hormuz-shock-could-ignite-a-surge-in-energy-and-defense-etfs">How A Strait Of Hormuz Shock Could Ignite A Surge In Energy And Defense ETFs</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

ETFs

GBUY

GSFP

BlackRock and Goldman Sachs Shutter ESG And Other Thematic ETFs Amid Waning Demand

Harris's 34-year track record of proven leadership at&nbsp;DTE and strong working relationship with Norcia to ensure a smooth, successful transition
DETROIT, June 23, 2025 /PRNewswire/ -- DTE Energy President and Chief Operating Officer Joi Harris will be named President and Chief Executive Officer of the company on Sept. 8, 2025, succeeding Jerry Norcia, Chairman and CEO, who will transition to serve as Executive Chairman of the Board.
The DTE Energy Board of Directors unanimously elected Harris to the post of Chief Executive Officer and as a member of the Board of Directors.

Management

DTE Energy Appoints Joi Harris As President And CEO, Effective Sept. 8, 2025, Succeeding Jerry Norcia, Chairman And CEO, Who Will Transition To Serve As Executive Chairman Of Board

Corcept Therapeutics Annouunces Data From Treatment Phase of CATALYST Trial At American Diabetes Association's 85th Scientific Sessions With Simultaneous Publication in Diabetes Care

Earnings

MGIH

Millennium Group International Holdings Revenues For Six Months Ended Dec. 31 $14.1M, Down 40.6% YoY; EPS $0.27, Up From $0.08 YoY

Events

NUVL

Nuvalent To Discuss Data For TKI Pre-treated Patients With Advanced ROS1-Positive NSCLC From ARROS-1 Clinical Trial Of Zidesamtinib

For nearly three decades, one retired couple made it a point to share everything equally. From splitting expenses to aligning their retirement goals, financial transparency was a cornerstone of their marriage. But a recent inheritance has introduced new tensions — and raised bigger questions about what fairness means in <a href="https://www.benzinga.com/personal-finance/25/02/43473640/can-you-guess-the-average-retirees-net-worth-surprisingly-it-tends-to-skyrocket-during-retirement">retirement</a>.
<h2 class="wp-block-heading">From "What's Mine Is Ours" to "What's Mine Is Mine"</h2>
According to a <a href="https://www.reddit.com/r/retirement/comments/1lbhiv9/when_an_inheritance_become_a_problem/">post</a> in the r/retirement subreddit, a retired man shared how he and his wife always kept finances equitable. Even after his wife became a stay-at-home mom in the 1990s, they continued to treat all money — earned or saved — as mutual property. That included small separate accounts for personal spending.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with simi</li>
</ul>
When she inherited $9,000 from her mother, she asked to keep it for herself. He agreed and matched it by moving $9,000 from their joint account into his own discretionary fund.
But when her father passed and left her around $55,000, the same arrangement met resistance. The husband asked to transfer $55,000 from their joint savings into his personal account to keep things even.&nbsp;
Her response? "No, it's too much money this time."
<h2 class="wp-block-heading">A Shift in Financial Philosophy</h2>
While the husband describes himself as stunned, he also says he tried to stay calm. "How does this affect me, really?" he asked himself. His wife's plan was to put the money into a certificate of deposit and possibly fund a trip to Ireland — something he said he would've supported even without the <a href="https://www.benzinga.com/personal-finance/25/04/44988979/23-year-old-received-50000-inheritance-and-turns-to-reddit-for-advice-how-should-i-invest-it">inheritance</a>.
Still, he couldn't help but notice the imbalance. With her recent inheritance, she now controls around $70,000 in personal funds. He has just $15,000. "It just feels kind of unfair," he wrote, noting that throughout their marriage, he had shared every dollar he earned.
Trending: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a><a href="https://www.benzinga.com/money/wideradvisor-retirement-planning"> obligation</a>.&nbsp;
<h2 class="wp-block-heading">Inheritance Laws vs. Relationship Norms</h2>
Commenters quickly pointed out that legally, the wife is within her rights. In most states, inheritances are not considered marital or community property — as long as they are kept separate and not deposited into joint accounts.
One commenter noted that keeping inherited funds separate could protect them in the event of <a href="https://www.benzinga.com/personal-finance/management/25/06/45975687/25000-monthly-care-costs-suze-orman-shows-how-long-term-care-insurance-can-protect-your-savings">long-term care</a> needs or other financial emergencies. "If she keeps the money separate, it will be protected if I have a catastrophic illness," the husband acknowledged. "That's reason enough to keep it separate."
Another user shared how their own mother had kept an inheritance separate for similar reasons — to preserve her financial identity and security, especially after years out of the workforce.
<h2 class="wp-block-heading">The Emotional Undercurrents</h2>
Though the legal side seems clear, emotional complexities remain. Many users shared stories of financial trust breaking down due to poor decisions, gambling, or infidelity. Others said inheritances had caused tension in otherwise stable marriages.
Despite the current conflict, the husband in the original post says he still views his wife's choice through a generous lens — and even plans to split any inheritance he might receive in the future with her.
"I may eventually inherit much more," he noted, "but I assume my dad will need it for assisted living. So it doesn't exist to me."
See Also: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no</a>
<h2 class="wp-block-heading">What Retirees Can Learn</h2>
For couples in retirement, inheritances can be a financial gift — or a relationship minefield. While the law offers one perspective, couples must also decide what fairness looks like within their own relationships.
Being open about expectations, aligning on shared values, and understanding the legal and emotional implications of separate versus <a href="https://www.benzinga.com/personal-finance/25/02/43768530/should-married-couples-split-expenses-dave-ramsey-says-no-youre-married-not-roommates">joint accounts</a> may help prevent larger rifts down the road.
Read Next: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
Image: Shutterstock

Personal Finance

She Inherited $55K And Refused To Share — Her Retired Husband Wonders What Happened To 28 Years Of Splitting Everything

Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced it will host an investor call and live webcast to review top-line data from the 16-week induction period in the ongoing global Phase 2b REZOLVE-AD clinical trial of investigational rezpegaldesleukin, a regulatory T-cell (Treg) proliferator, for moderate-to-severe atopic dermatitis on Tuesday, June 24, 2025 at 8:15am ET / 5:15am PT.
The data will be provided in a morning press release and presented during the webcast.&nbsp;Details on how to access the live webcast of the call will be available in the morning press release and on the Nektar website at <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4454961-1&amp;h=3668145578&amp;u=http%3A%2F%2Fwww.nektar.com%2F&amp;a=www.nektar.com">www.nektar.com</a>. A replay of the webcast will be available for at least 30 days following the event.

Nektar Announces It Will Release Top-Line Data from 16-Week Induction Period In REZOLVE-AD Phase 2b Study of Rezpegaldesleukin On June 24, 2025

The contract includes multiple high-performance radio frequency components, including rugged crystal filters and lumped element filters, engineered for durability and precision in mission-critical environments. This latest award builds on Mtron's long-standing support of the program, which has supplied specialized components for nearly a decade.

MPTI

Mtron Wins $5.5M Production Contract For U.S. Naval Weapon System

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed up 107.84% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 22.35% at $0.50</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed up 17.05% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 15.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 12.30% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 10.91% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 4.80% at $0.45</li>
<li><a href="https://www.benzinga.com/quote/ESE">ESCO Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed up 4.30% at $189.26</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 4.14% at $0.36</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 3.33% at $0.10</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 66.67% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/BGRDF">HYLQ Strategy</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BGRDF#OTC">BGRDF</a>) shares closed down 64.97% at $1.00</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 21.43% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CANN">Trees</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANN#OTC">CANN</a>) shares closed down 18.12% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 12.73% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 9.62% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 8.89% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 8.43% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 5.41% at $1.05</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 5.16% at $8.11</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 5.11% at $3.27</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 5.01% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 4.25% at $7.89</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed down 4.19% at $3.91</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 3.65% at $0.32</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 3.40% at $0.28</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Growth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 3.23% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 3.18% at $0.77</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

BBRRF

BGRDF

BLGVF

CANN

CBDY

CRBP

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CWBHF

ELLXF

FFNTF

GRWG

ITHUF

KAYS

LMLLF

LVRLF

NWVCF

OILFF

RSSFF

TCNNF

TGIFF

TLRY

UGRO

XXII

Marijuana Stock Movers For June 23, 2025

A senior U.S. official revealed on Monday that the Chinese AI company DeepSeek is supporting the Asian nation&#8217;s military and intelligence agencies and found ways around U.S. export restrictions on <a href="https://www.benzinga.com/markets/tech/25/06/46035836/nvidia-broadcom-marvell-and-other-chip-stocks-fall-on-unexpected-us-move">advanced semiconductor chips. </a>
The Details: DeepSeek provided AI technology that uses advanced U.S. chips to China's military, despite Washington&#8217;s efforts to prevent such tech from being accessible to China, according to a Reuters report. 
Read Next:<a href="https://www.benzinga.com/news/space/25/06/46055895/ast-spacemobile-stock-downgraded-rocket-lab-prepares-electron-launch-space-stock-countdown?utm_source=articleShare"> AST SpaceMobile Stock Downgraded, Rocket Lab Prepares Electron Launch: Space Stock Countdown</a>
&#8220;We understand that DeepSeek has willingly provided and will likely continue to provide support to China&#8217;s military and intelligence operations,&#8221; a senior State Department official told Reuters in an interview.
The official said that DeepSeek provides Beijing's surveillance operators with user information and statistics.&nbsp;
&#8220;This effort goes above and beyond open-source access to DeepSeek&#8217;s AI models,&#8221; the anonymous official said.
The same U.S.official told Reuters that DeepSeek was using "workarounds" to gain access to advanced chips from the U.S. and that the company has access to &#8220;large volumes&#8221; of NVIDIA Corp.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) H100 chips.&nbsp;
Three separate sources familiar with the matter also told Reuters that DeepSeek has Nvidia's H100 chips that it obtained after the U.S. banned Nvidia from selling those chips to China
&#8220;Our review indicates that DeepSeek used lawfully acquired H800 products, not H100,&#8221; an Nvidia spokesman said, responding to Reuters about DeepSeek&#8217;s alleged usage of H100 chips.
DeepSeek has not publicly responded to these allegations.&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/06/46056665/unitedhealth-cvs-among-major-insurers-to-fast-track-prior-authorizations-will-it-cut-profits-even-more?utm_source=articleShare">UnitedHealth, CVS Among Major Insurers To Fast-Track Prior Authorizations: Will It Cut Profits Even More?</a></li>
</ul>
Image: Shutterstock

Large Cap

Global

Tech

NVDA

Nvidia's Best Chips May Be Powering China's Military—Via DeepSeek

Amgen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) shares are trading lower by 5.7% to $272.88 Monday afternoon after the company released full results from part one of its phase two study of MariTide, its investigational obesity treatment.
What To Know: The therapy, a long-acting, peptide-antibody conjugate administered monthly or less frequently, showed promising <a href="https://www.benzinga.com/pressreleases/25/06/n46060156/results-from-amgens-phase-2-obesity-study-of-monthly-maritide-presented-at-the-american-diabetes-a">weight loss benefits</a> but failed to boost investor confidence.
In the phase two trial, MariTide showed up to 20% average weight loss in people with obesity without Type 2 diabetes and up to 17% in those with the condition, significantly outperforming placebo.
Additionally, MariTide <a href="https://www.benzinga.com/pressreleases/25/06/n46060156/results-from-amgens-phase-2-obesity-study-of-monthly-maritide-presented-at-the-american-diabetes-a">delivered</a> notable reductions in hemoglobin A1c (up to 2.2%) and improvements in several cardiometabolic measures. Importantly, weight loss did not plateau by 52 weeks.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46060610/fractyl-health-stock-is-trading-lower-monday-whats-going-on">Fractyl Health Stock Is Trading Lower Monday: What&#8217;s Going On?</a>
Safety data showed gastrointestinal side effects, mostly mild to moderate, with improved tolerability during dose escalation. The findings also included data from the phase one PK-LDI study, which assessed dosing strategies and showed low discontinuation rates.
Despite the strong clinical results, the market reaction was negative, possibly due to concerns about competitive pressures in the GLP-1 space or the long road ahead for phase three trials.
Amgen launched its MARITIME Phase 3 program and plans additional studies targeting cardiovascular disease, heart failure and sleep apnea. An investor webcast is scheduled Monday evening.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, AMGN has a 52-week high of $346.85 and a 52-week low of $253.30.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46059932/kratos-defense-stock-is-rising-monday-whats-going-on-2">Kratos Defense Stock Is Rising Monday: What&#8217;s Going On?</a>
<h1 class="wp-block-heading">How To Buy AMGN Stock</h1>
Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, Amgen is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46059497/stocks-rise-oil-tumbles-despite-irans-strikes-on-us-bases-whats-driving-markets-monday">Stocks Rise, Oil Tumbles Despite Iran&#8217;s Strikes On US Bases: What&#8217;s Driving Markets Monday?</a></li>
</ul>
Image: Courtesy of Amgen

Health Care

AMGN

Amgen (AMGN) Stock Falls After Mixed MariTide Trial Update

Offerings

CHWY

Chewy Announces $1B Public Offering Of Class A Common Stock; In Addition, Chewy Has Agreed To Purchase From The Selling Stockholder $100.0M Of Class A Common Stock

Press Releases

Federated Hermes wins 2025 LSEG Lipper Fund Awards

Month-end portfolio data now available for Federated Hermes Premier Municipal Income Fund

Federated Hermes, Inc. announces first quarter 2025 earnings and conference call dates

Dividends

Federated Hermes Premier Municipal Income Fund declares dividend

Federated Hermes, Inc. reports record assets under management with first quarter 2025 earnings

Comments

Federated Hermes

Noticias

Últimas noticias sobre Federated Hermes (NYSE:FHI) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL